Farmacología y Electrofisiología Cardiovascular
![Foto de Farmacología y Electrofisiología Cardiovascular](/img/grupo.png)
![Foto de Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias](/img/noimage_org.png)
Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias
Madrid, EspañaCentro de Investigacion Biomedica en Red de Enfermedades Respiratorias-ko ikertzaileekin lankidetzan egindako argitalpenak (7)
2019
-
Cardiovascular effects of flavonoids
Current Medicinal Chemistry, Vol. 26, Núm. 39, pp. 6991-7034
2016
-
Role of UCP2 in the protective effects of PPARβ/δ activation on lipopolysaccharide-induced endothelial dysfunction
Biochemical Pharmacology, Vol. 110-111, pp. 25-36
2013
-
Effects of peroxisome proliferator-activated receptor-β activation in endothelin-dependent hypertension
Cardiovascular Research, Vol. 99, Núm. 4, pp. 622-631
2012
-
Activation of peroxisome proliferator-activated receptor-β/-δ (PPARβ/δ) prevents endothelial dysfunction in type 1 diabetic rats
Free Radical Biology and Medicine, Vol. 53, Núm. 4, pp. 730-741
-
Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension
Free Radical Biology and Medicine, Vol. 52, Núm. 1, pp. 70-79
-
Glucuronidated quercetin lowers blood pressure in spontaneously hypertensive rats via deconjugation
PLoS ONE, Vol. 7, Núm. 3
2010
-
Vascular superoxide production by endothelin-1 requires Src non-receptor protein tyrosine kinase and MAPK activation
Atherosclerosis, Vol. 212, Núm. 1, pp. 78-85